Targeted sequencingis essential when your research requires high coverage of specific genes, structural variants, or microbial genomes without the cost and data burden of whole genome sequencing. N2 Jenomics Lab Pvt. Ltd. offers a comprehensive Nanopore Targeted Sequencing service, enabling researchers to enrich regions of interest in real time using amplicon sequencing, CRISPR-Cas9 enrichment, or adaptive sampling.
Our service helps clients overcome the limitations of traditional targeted approaches—such as PCR bias, probe dependency, and loss of epigenetic information—by leveraging long-read nanopore sequencing. With the ability to simultaneously capture SNVs, SVs, repeats, and methylation states, we deliver deeper biological insights and actionable data for biochemistry labs, academic institutions, and CRO clients worldwide.
Key benefits:
Nanopore Targeted Sequencing enables researchers to focus sequencing effort on the most relevant parts of the genome—whether specific genes, regions with high biological significance, or rare microbial taxa—while avoiding unnecessary sequencing of background DNA.
Unlike traditional methods that require PCR amplification or hybridization capture, nanopore technology offers flexible strategies to perform targeted sequencing:
Nanopore Amplicon-based approaches for cost-effective profiling of PCR products
Cas9-targeted sequencing for precise enrichment of disease- or AMR-related genes
Adaptive sampling, a unique software-driven method, which enriches or depletes DNA fragments during sequencing without any additional lab steps
This flexibility makes nanopore targeted sequencing particularly powerful for applications in oncology, microbiology, epigenetics, and evolutionary studies.
Nanopore sequencing supports any read length from 50 bp to >4 Mb, providing the ability to span large structural variants, repetitive elements, and GC-rich regions that short-read methods fail to resolve.
Unlike PCR- or probe-based enrichment, nanopore targeted sequencing directly analyzes native DNA and RNA molecules, retaining methylation and base modification signals essential for regulatory and cancer research.
Adaptive sampling allows researchers to monitor data output during the run, enriching or depleting reads of interest in real time. This reduces turnaround time and ensures efficient use of sequencing capacity.
With no need for expensive capture panels or extensive optimization, nanopore targeted sequencing provides a faster and more scalable path to results compared to legacy methods.
| Feature | Nanopore Targeted Capture | Nanopore Whole Genome | Illumina Targeted Capture |
| Read Length | Long reads | Long reads | Short reads |
| Variation | Complex structural variations epigenetic modifications | whole-genome variations epigenetic modifications | SNVs/Indels |
| Real-time Sequencing | Yes | Yes | No |
| Amplification Bias | No | No | Yes |
| Portability | High | High | Low |
| Throughput | Moderate | Moderate | High |
| Cost | Moderate | High | Moderate |
At N2 Jenomics Lab Pvt. Ltd. , we offer carefully designed service packages for Nanopore Targeted Sequencing to meet diverse research requirements. Each package falls under the umbrella of targeted sequencing — selecting specific genomic regions of interest — but differs in methods, input requirements, and delivered data. Review the options below and select the package that aligns best with your project goals, sample quality, and budget.
| Package Name | Best For / Use Cases | Input & Sample Requirements | What's Included | Advantages |
|---|---|---|---|---|
| Basic Amplicon Package | Projects focused on specific hotspot mutations, small gene panels, 16S / ITS barcoding, microbial marker identification | DNA ≥ 50–100 ng; acceptable fragment size ≥ ~500-1000 bp; targets well known; moderate number of loci | PCR primer design; PCR amplification; nanopore sequencing of amplicons; SNV / small indel calling; basic QC report | Low cost; fast turnaround; well-suited for labs with limited sample material; high depth over few targets |
| Cas9 / Panel Deep-Target Package | Medium to large gene panels; structural variant detection; challenging or repetitive regions; preservation of methylation and epigenetic features | High quality DNA (≥ 200-500 ng), long fragment size preferred (>10-20 kb); minimal degradation; sufficient sample purity | Guide RNA design; Cas9-mediated enrichment; long-read nanopore sequencing; SNV + SV calling; optional methylation profiling; detailed report | Probe‐free targeting of difficult regions; retains native DNA modifications; capable of detecting large insertions / deletions and mobile elements |
| Adaptive Sampling Package | Projects needing flexibility: changing target coordinates on the fly; host / background DNA depletion; rare targets in mixed samples | Genomic DNA of good quality; quantity varies by target size; input requirement depends on proportion of genome targeted; BED file of target coordinates provided | Setup of adaptive sampling in MinKNOW; sequencing with on-device enrichment or depletion; real-time monitoring; SNV, SV, base modification analysis; QC & coverage statistics | No extra wet lab enrichment; rapid setup; dynamic targeting; good for environmental or metagenomic samples with background DNA issues |
| Comprehensive Panel + Multi-Omics Package | Testing many genes (e.g. hereditary cancer panels), integrating mutation, structure, methylation, and haplotype data; large studies requiring full feature set | High input (≥ ~500 ng–1 µg depending on targets); high DNA integrity; long fragments strongly desirable; sample QC required | Full panel enrichment (via Cas9 or hybrid probe designs); long-read data; SNV / SV / indel calling; DNA methylation / epigenetic modifications; haplotype phasing; full QC / annotation; comprehensive reporting | Rich data in one experiment; covers all variant types + epigenetic marks; useful for in-depth disease genetics, trait mapping, functional genomics |

Workflow of N2 Jenomics Lab Pvt. Ltd. Nanopore Targeted Sequencing, from DNA extraction and target definition to enrichment, long-read sequencing, and bioinformatics reporting.

Years of expertise in genomics sequencing across Illumina, PacBio, and Nanopore platforms
CRO-grade reliability, trusted by pharma, biotech, and academic institutions
Flexible project design: from single targets to full cancer gene panels
Comprehensive bioinformatics support: variant annotation, methylation mapping, AMR gene tracking
End-to-end service: sample QC, sequencing, data analysis, secure data portal delivery
| Sample Type | Recommended Quantity/Input | Minimum Quantity/Input | Minimum Concentration / Purity | Notes on Integrity / Handling |
|---|---|---|---|---|
| High-Molecular-Weight Genomic DNA | ≥ 5 µg in total, concentration ≥ 20-50 ng/µL | ≥ 3 µg | OD 260/280 ≈ 1.8; OD 260/230 ≈ 2.0-2.2; RNase-treated; free of visible protein, phenol, detergent contamination | Average fragment size large (ideally ≥ 30 kb); minimal degradation; stored in a buffer such as 10 mM Tris pH 8.0-8.4; shipped cold (ice-packs or dry-ice) |
| Microbial / Environmental DNA | ≥ 500 ng | ≥ 300-500 ng | ≥ ~10 ng/µL; high purity (no inhibitors) | If sample includes host or contaminants, consider host depletion or choosing adaptive sampling paths; properly frozen or stabilized during transport. |
| Tissue or Cell Samples | Enough input to yield high-molecular-weight DNA (typically ≥ few µg) | As high as possible; degraded or low-yield samples may compromise long reads | Purity same as above; DNA free of RNA / protein contaminants; minimal DNA degradation | Fresh or snap frozen preferred; avoid repeated freeze-thaw; for tissues, thinner slices help; storage and transport on dry ice or blue ice. |
Taxonomic Resolution Improvement ![]() Comparison of microbial classification resolution between short-read and nanopore long-read amplicon sequencing. | Consensus Accuracy with Error Suppression
![]() |
Community Diversity Analysis ![]() Adaptive sampling enhances detection of rare microbial taxa by depleting host DNA background. |
Structural Variant & Repeat Resolution ![]() Cas9-targeted enrichment reveals structural variants and repeat expansions with breakpoint resolution. | Epigenetic Insights from Native DNA ![]() Direct detection of DNA methylation during nanopore targeted sequencing of native DNA. |
Q1: What is nanopore targeted sequencing and how does it differ from whole-genome sequencing?
Nanopore targeted sequencing focuses on specific genomic regions of interest—such as genes, hotspots, or structural variant breakpoints—rather than sequencing the entire genome. This approach enables higher coverage of those targets, less data waste, and retention of long reads and epigenetic modifications. Whole-genome sequencing provides comprehensive coverage but is more costly and generates more data than needed for focused studies.
Q2: What are the different methods or "routes" to do targeted sequencing with nanopore technology?
There are several approaches: (1) PCR-based amplicon sequencing for well-defined small targets; (2) probe or hybrid capture panels (less common in nanopore but available via custom or third-party designs); (3) CRISPR-Cas9 enrichment, which is amplification-free and suited for structural variants and difficult genomic regions; and (4) adaptive sampling, which enriches or depletes reads in real time using software without additional wet-lab steps.
Q3: What is the difference between nanopore amplicon sequencing and other targeted sequencing methods?
Amplicon sequencing is PCR-based, cost-effective, and rapid, but it may introduce amplification bias, miss GC-rich or repetitive regions, and remove methylation information. Cas9 enrichment or adaptive sampling avoids PCR, preserves methylation, and captures structural complexity across long genomic regions.
Q4: How does nanopore Cas9 targeted sequencing compare with hybrid capture?
Cas9 enrichment is faster, simpler, and probe-free, producing long reads that resolve repeats and structural variants better. Hybrid capture is useful for broad panels, but requires probe design, more steps, and may not capture complex structural contexts as effectively.
Q5: Can nanopore targeted sequencing detect epigenetic modifications such as DNA methylation?
Yes. When using amplification-free methods like Cas9 enrichment or adaptive sampling, nanopore sequencing directly detects base modifications, including methylation, without additional chemical treatments or library preparation.
Q6: Can adaptive sampling be applied to low-input or degraded DNA?
Yes, adaptive sampling works with standard nanopore libraries. For highly fragmented or low-input DNA, such as FFPE or ancient samples, modified protocols can help improve performance, although enrichment efficiency depends on fragment size and quality.
Q7: What are the limitations or trade-offs of nanopore targeted sequencing compared to short-read or PCR-based methods?
Nanopore sequencing may have lower single-read accuracy than short-read platforms, though coverage and consensus improve results. Amplicon methods can suffer from PCR bias, while adaptive sampling efficiency depends on target size and DNA length. In contrast, nanopore sequencing delivers long reads, preserves methylation, and resolves structural variants and repeats that short-read or PCR-only approaches cannot.
Q8: What sample quality and input are required for reliable targeted sequencing results?
High molecular weight DNA is preferred, with minimal degradation, proper purity ratios (OD 260/280 ~1.8; OD 260/230 ~2.0–2.2), and sufficient concentration. Amplicon sequencing tolerates smaller or more fragmented inputs, while Cas9 enrichment and adaptive sampling perform best with longer DNA fragments and high-quality preparations.
Q9: Which nanopore device should I choose for targeted sequencing projects?
Device selection depends on scale and complexity. MinION is suitable for small panels or individual targets, while GridION or PromethION are recommended for larger panels, multiple samples, or projects requiring higher throughput. Multiplexing options, flow cell type, and read length goals also influence device choice.
Q10: How is adaptive sampling set up and what does it do for targeted sequencing?
Adaptive sampling is configured in MinKNOW by providing reference files and optional BED coordinates for target regions. During sequencing, software evaluates read starts in real time, allowing on-target reads to continue while rejecting off-target reads to free pores. This provides enrichment or depletion without extra wet-lab enrichment, with effectiveness depending on target size and input DNA quality.
Q11: How many variants can be detected reliably with nanopore targeted sequencing?
Nanopore targeted sequencing can detect SNVs, small indels, structural variants such as large deletions or inversions, repeat expansions if reads span them, and haplotypes when coverage and read length allow. Sensitivity and specificity depend on target design, sequencing depth, and DNA quality.
Q12: What bioinformatics deliverables are included in a standard project?
Typical deliverables include raw reads (FASTQ), alignments (BAM), variant calls (VCF for SNVs, indels, SVs), coverage and enrichment statistics, optional methylation or base modification files, and graphical summaries such as variant maps or structural variant plots. Annotation reports linking results to genes, known variants, or pathways are also provided.
Source: Weiwei Gao, Chen Yang, Tianzhen Wang, Yicheng Guo, Yi Zeng (2024). Nanopore-based targeted next-generation sequencing of tissue samples for tuberculosis diagnosis. Frontiers in Microbiology 15:1403619. DOI: 10.3389/fmicb.2024.1403619.
Diagnosing tuberculosis (TB) in tissue (extrapulmonary TB, EPTB) is difficult when sputum is unavailable. Traditional methods (HE staining + AFB, HE + PCR, HE + IHC, Xpert MTB/RIF) often yield low sensitivity with tissue samples. This study investigates whether nanopore-based targeted next-generation sequencing (tNGS) can improve diagnostic sensitivity and specificity in tissue samples, including detection of potential drug resistance.

Figure 1. Sensitivity and specificity of tNGS versus conventional diagnostic methods for TB in tissue samples (HE + AFB, HE + PCR, HE + IHC, Xpert MTB/RIF.
Nanopore tNGS on tissue samples performs substantially better than traditional histopathology + molecular methods for diagnosing TB, including in extrapulmonary tissue where bacterial load is low. It also provides drug resistance insights, making it a valuable tool for rapid and accurate diagnosis in clinical settings. The study supports using tNGS as a complement to existing diagnostics for TB.
References: